
Douglas Mason/WireImage
Coronary heart introduced on Tuesday (July 2) that the group is suspending the rest of its North American tour dates headlining Royal Flush Tour and Journey/Def Leppard Stadium tour, as a consequence of frontwoman Ann Wilson’s latest well being points.
“I underwent an operation to take away one thing that, because it seems, was cancerous,” Wilson shared in a press assertion. “The operation was profitable & I’m feeling nice however my docs at the moment are advising me to bear a course of preventive chemotherapy & I’ve determined to do it. And so my docs are instructing me to take the remainder of the 12 months away from the stage in an effort to absolutely get better. To the ticket patrons, I actually do want we might do these gigs. Please know that I completely plan to be again on stage in 2025. My group is getting these particulars sorted & we’ll let you realize the plan as quickly as we are able to.”
Wilson concluded by noting, “That is merely a pause. I’ve far more to sing.”
Followers are inspired to carry on to their tickets for the upcoming postponed dates. In Could, Coronary heart canceled their European tour dates.
Began by sisters Ann and Nancy Wilson in 1974, Coronary heart’s Royal Flush tour marks the band’s return to the highway for the first time in 5 years. The North America leg kicked off April 20 in Greenville, South Carolina, with Low-cost Trick as help on most dates, whereas Squeeze was set to open on a handful of these now-canceled summer time European dates.
Acknowledged as the primary female-fronted arduous rock band, Coronary heart took their place among the many greats once they had been inducted into the Rock And Roll Corridor of Fame in 2013.

